Aptorum Group Limited (APM)
NASDAQ·Healthcare·Biotechnology
$0.88
-1.73%
Mkt Cap $5.08M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Jan 22, 2026 | — | — | — | — | -$0.06 | — | — | — |
| Q2 2025 Apr 28, 2025 | — | — | — | — | -$0.29 | — | — | — |
| Q4 2024 Dec 20, 2024 | — | — | — | — | -$0.50 | — | — | — |
| Q2 2024 Apr 30, 2024 | $1.30M | — | — | -$2.70 | $0.51 | +119.04% | — | — |
| Q4 2023 Dec 22, 2023 | $1.00M | $431.38K | -56.86% | -$2.60 | -$1.43 | +45.19% | — | — |
| Q2 2023 Apr 28, 2023 | $800.00K | $768.43K | -3.95% | -$2.60 | -$2.22 | +14.76% | — | — |
| Q3 2022 Sep 30, 2022 | $800.00K | $527.46K | -34.07% | -$3.00 | -$0.53 | +82.39% | — | — |
| Q2 2022 Apr 29, 2022 | $700.00K | $903.99K | +29.14% | -$3.30 | -$2.52 | +23.76% | — | — |
| Q4 2021 Dec 3, 2021 | $600.00K | $637.78K | +6.30% | -$3.00 | -$4.69 | -56.37% | — | — |
| Q2 2021 Apr 19, 2021 | $400.00K | $584.24K | +46.06% | -$3.10 | $3.90 | +225.81% | — | — |
| Q3 2020 Sep 1, 2020 | $300.00K | $327.27K | +9.09% | -$2.50 | -$2.07 | +17.16% | — | — |
| Q2 2020 Apr 29, 2020 | — | $295.37K | — | — | -$3.31 | — | — | — |
| Q3 2019 Sep 9, 2019 | — | $239.79K | — | — | -$3.14 | — | — | — |
| Q2 2019 Apr 15, 2019 | — | $383.45K | — | — | -$5.31 | — | — | — |
| Q4 2018 Dec 4, 2018 | — | $26.66K | — | — | -$1.89 | — | — | — |